Australia markets close in 21 minutes

Starpharma Holdings Limited (SPL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.7150-0.0250 (-3.38%)
As of 03:14PM AEST. Market open.
Currency in AUD

Valuation measures4

Market cap (intra-day) 273.66M
Enterprise value 226.11M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)86.91
Price/book (mrq)4.97
Enterprise value/revenue 72.22
Enterprise value/EBITDA -11.99

Trading information

Stock price history

Beta (5Y monthly) 1.40
52-week change 3-50.50%
S&P500 52-week change 3-13.03%
52-week high 31.5300
52-week low 30.6200
50-day moving average 30.7547
200-day moving average 31.0025

Share statistics

Avg vol (3-month) 3369.52k
Avg vol (10-day) 3602.37k
Shares outstanding 5408.44M
Implied shares outstanding 6N/A
Float 8381.05M
% held by insiders 16.64%
% held by institutions 147.47%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 425 Mar 1988
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-541.68%

Management effectiveness

Return on assets (ttm)-15.96%
Return on equity (ttm)-28.44%

Income statement

Revenue (ttm)3.43M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)199.80%
Gross profit (ttm)-13.71M
EBITDA -18.24M
Net income avi to common (ttm)-17.75M
Diluted EPS (ttm)-0.0440
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)51.25M
Total cash per share (mrq)0.13
Total debt (mrq)3.71M
Total debt/equity (mrq)6.73
Current ratio (mrq)7.01
Book value per share (mrq)0.14

Cash flow statement

Operating cash flow (ttm)-20.68M
Levered free cash flow (ttm)-13.8M